Development Pipeline

The future of drug delivery.

From skin patches to minimally invasive microneedle system and innovative skin insertion platforms, and from solid or liquid dosing, to existing or new drugs, we have a significant and robust pipeline of carefully selected drug candidates in various stages of clinical development.

Our research is always underpinned by exceptional science and driven by our years’ of expertise in drug delivery and pharmaceutical product development.

Transdermal Patch

Alzheimer'sParkinson'sHypertension
ANDA/MAA Approved
ANDA/MAA Submitted
Clinical Development

Microneedle - Medical Device Applications

Skin prep / DermatologyDermatologyDiagnostic
CE Mark Approved
Clinical Development
Pre-clinical Development

Microneedle - Drug Delivery Applications

Diabetes: QSR4201Diabetes: QSR4203Topical Pain ReliefLocal Anesthesia: QSR4212Migraine: QSR4213Chronic Pain Management: QSR4213CNS: QSR4251
ANDA/MAA Approved
ANDA/MAA Submitted
Clinical Development
Pre-clinical Development


OsteoporosisVaccine - Human: QSR42111Oncology: QSR4291DVT: QSR4251Antibiotic - Veterinary LSR4209Vaccine - Veterinary: LSR4211
ANDA/MAA Approved
ANDA/MAA Submitted
Clinical Development
Pre-clinical Development

Additional products under development for licensees – details undisclosed.